baber/WOPTO huggingface dataset:
Patent AT-E75991-T1 (AT)
Inventor: CHRISTOFFERSSON BJOERN
IPC: B26F1/38
Filed: 1990-06-05
Granted: 1992-05-15
Abstract: The invention relates to an apparatus for the removal of areas of material punched out from a material in sheet form by projecting, closed punching edges on the circumferential surface of at least one rotating punching cylinder by means of compressed air, which is fed into the punching cylinder and led out from the punching cylinder through outlet openings lying within the closed punching edges, wherein the compressed air from an opening in a side face of a member at least partially embracing the punching cylinder in a guided manner is fed to inlet openings assigned to the outlet openings, which inlet openings are located in a side face of the punching cylinder closely adjacent to the side face of the member.
Patent AT-E115948-T1 (AT)
Inventor: FLYNN GARY A
IPC: A61K31/40
Filed: 1990-07-17
Granted: 1995-01-15
Abstract: Novel cyclic vinylogous N-hydroxy-N-methylureas are useful in the treatment of leukotriene mediated conditions such as asthma and rheumatoid arthritis.
Patent AT-E145938-T1 (AT)
Inventor: SEED BRIAN
IPC: A61K38/00
Filed: 1990-08-18
Granted: 1996-12-15
Abstract: The invention relates to substantially pure non-human primate CD4, and fragments thereof which bind to HIV or SIV gp120. The invention also relates to gp120 binding molecules related to human CD4 but which may exist in glycosylated form. The invention also relates to fusion proteins which comprise the CD4 molecules of the invention, or fragments thereof, and an immunoglobulin light or heavy chain, wherein the variable region of the light or heavy chain has been replaced with CD4 or fragment thereof which is capable of binding to gp120. The invention also relates to fusion proteins comprising the CD4 molecules of the invention and a cytotoxic polypeptide. The invention also relates to an immunoglobulin-like molecules comprising the fusion proteins of the invention together with an immunoglobulin light or heavy chain. The invention also relates to methods of treating HIV or SIV infection comprising administering the CD4 molecules of the invention, glycoproteins, fragments thereof, fusion proteins or immunoglobulin-like molecules of the invention to an animal. The invention also relates to assays for HIV or SIV comprising contacting a sample suspected of containing HIV or SIV gp120 with the CD4 molecules of the invention, fragments thereof, glycoproteins, immunoglobulin-like molecules, or fusion proteins of the invention, and detecting whether a complex is formed. The invention also relates to nucleic acid molecules which specify the proteins, glycoproteins and fusion proteins of the invention as weil as vectors and transformed hosts.
Patent AT-E104404-T1 (AT)
Inventor: DYER JOHN
IPC: F15B15/08
Filed: 1990-11-02
Granted: 1994-04-15
Abstract: A geared air actuator comprising a piston 30 mounted for movement within a housing 3. The piston 30 has a front wall 31 and a hollow body portion 33 which extends rearwardly from the front wall 31. A spring 40 is mounted within the hollow body portion 33 of said piston 31. When pneumatic fluid is introduced into the housing 3 and against the front of the piston 30, it moves the piston 30 back against the action of the spring 40. When the introduction of pneumatic fluid is terminated the spring 40 will move the piston 30 back to its original position. The front wall 31 of the piston 30 is substantially thinner than the length of the body portion. <IMAGE>
Patent AT-E141595-T1 (AT)
Inventor: LAI JOHN TA-YUAN
IPC: C07B61/00
Filed: 1990-12-20
Granted: 1996-09-15
Abstract: A process is disclosed for making a 1,4-diazacycloheptan-2-one from a mixture ('first' mixture) of alkylated 1,3-propanediamines one of which (referred to as the 'target' diamine) has substituents at specifed positions and contains (i) a terminal primary amine group adjacent to a disubstituted C atom (hence, referred to as having a 'hindered' N atom), and (ii) a terminal secondary amine group. The target diamine, other diamines and oligomeric polyamines in the first mixture, are made by alkylating an acyclic ('starting') 1,3-propanediprimaryamine having the hindered N atom. The first mixture of alkylated diamines, preferably containing a major molar proportion of the target diamine relative to any other alkylated diamines, is reductively alkylated, which unexpectedly results in the reductive alkylation of only the unwanted diamines, allowing the target diamine which is not reductively alkylated, to be removed from the mixture of reductively alkylated diamines. Upon cyclization of the target diamine, using the "ketoform reaction", it is essentially quantitatively converted to the 1,4-diazacycloheptan-2-one having an unsubstituted N<4> atom flanked by disubstituted adjacent C atoms. By removing the unwanted components in the reaction mass an essentially pure product of 1,4-diazacycloheptan-2-ones is recovered. Thus, the difficulty of separating the target amine from other close-boiling compounds is avoided. As an alternative, the reductive alkylation step can be bypassed and the first mixture subjected to the ketoform reaction, followed by recovery of the desired product.
Patent AT-E119757-T1 (AT)
Inventor: URIE ROBERT GRAHAM
IPC: A61B17/00
Filed: 1990-04-17
Granted: 1995-04-15
Abstract: A lesion location device suitable for marking a lesion in breast tissue comprises a wire 1, of which the first portion 2 which has been bent 4 to form a second portion 3 at an obtuse or acute angle to the first portion, a 180 DEG  bend 5 and a third portion 6 which extends adjacent the second portion and continues beyond the bend 4 in a direction substantially opposed to that of the second portion. The bend 4 is resiliently pivotable and forms a spring mechanism to prevent ingress of the wire once in position in the lesion. Two graduated cannulas are also provided, one 7 with a pointed end 8 and one 9 with a blunt end 10, which are suitable for the wire 1 to be passed into them.
Patent AT-E105771-T1 (AT)
Inventor: DRIVER HOWARD DANIEL
IPC: B29C65/78
Filed: 1990-12-05
Granted: 1994-06-15
Abstract: An ordered staple fiber/resin tape is steerable during tape laydown by applying sufficient heat and back tension to the tape before laydown to maintain the ordered staple fibers in tension across the width of the tape. <IMAGE>
Patent AT-E140075-T1 (AT)
Inventor: CLARK KIMBLE JOHN DR
IPC: F22B35/18
Filed: 1990-11-30
Granted: 1996-07-15
Abstract: A method for increasing the reliability and remaining useful life of a system of boiler tubes. The present condition of boiler tubes is ascertained and a temperature profile is developed. Additional operating parameters are obtained and used to model the tube system. The model is manipulated to predict a modification which will cause increased tube system life and reliability. The tubes are modified according to the model. <IMAGE>
Patent AT-E111128-T1 (AT)
Inventor: SULTAN BERNT-AKE
IPC: C08J3/24
Filed: 1989-12-19
Granted: 1994-09-15
Abstract: A crosslinkable polymer composition comprises an olefin copolymer or graft copolymer with hydrolysable saline groups and a silanol condensation catalyst, as well as a silane compound with at least one hydrolysable organic group. The polymer composition is characterized in that the silane compound has a compatibility with the polymer composition of at least 0.035 mole hydrolysable groups per 100 g polymer composition, and in that the silane compound is represented by the general formula: R1(SiR2nX3-n)m, wherein R1 is a monofunctional hydrocarbyl group having 13-30 carbon atoms, or a difunctional hydrocarbyl group having 4-24 carbon atoms, R2 is a hydrocarbyl group having 1-10 carbon atoms, X is a hydrolysable organic group, n is 0, 1 or 2, and m is 1 or 2.
Patent AT-E118937-T1 (AT)
Inventor: COOPER ANTHONY JAMES
IPC: H04B10/25
Filed: 1990-02-02
Granted: 1995-03-15
Abstract: PCT No. PCT/GB90/00157 Sec. 371 Date Aug. 16, 1991 Sec. 102(e) Date Aug. 16, 1991 PCT Filed Feb. 2, 1990 PCT Pub. No. WO90/09709 PCT Pub. Date Aug. 23, 1990.An optical communications system comprises a transceiver arranged to provide two-way communication over an optical communications channel (3). The transceiver comprises a semiconductor light source (4) and a detector (5). The semiconductor light source (4) provides optical signals for transmission via the optical communications channel (3), and the detector (5) detects optical signals received via the optical communications channel and converts said optical signals into electrical signals. Means (2)a, (2)b) are provided for modulating the output of the semiconductor light source (4) with an RF carrier having a first frequency. Said electrical signals are passed through filter (8) adapted to filter out signals at said first frequency.
Patent AT-E131568-T1 (AT)
Inventor: KORB KLAUS
IPC: E05B63/04
Filed: 1991-02-25
Granted: 1995-12-15
Abstract: The drive rod lock as a bolt (35) and catch (33) protruding through a cover plate (1), and a slider(s) (53) coupled to rods and moved by a key. The slider is of angular shape, its arm (101) above the catch extending towards the cover plate. The arm is pref. inserted in a space in the catch, open towards the latter narrow side. In the retracted position of the catch, the arm can move via the space over the portion (102) of the slider, parallel to the cover plate.
Patent AT-E128475-T1 (AT)
Inventor: WALTER MANFRED DR
IPC: C08J9/00
Filed: 1991-07-26
Granted: 1995-10-15
Abstract: Bead-form, antistatic, expandable styrene polymers containing 
 
  a) a styrene polymer, 
  b) from 0.5 to 3% by weight, based on a), of a coating containing 
 
  b1)from 10 to 70% by weight of finely divided silica, 
  b2)from 20 to 80% by weight of a hydroxyl-containing quaternary ammonium salt and, if desired, 
  b3)from 0.05 to 20% by weight of a conventional adhesion promoter and 
  b4)from 10 to 30% by weight of a conventional agent for shortening the cooling time, 
 
  c) from 1 to 8% by weight, based on a), of a C3- to C6-hydrocarbon as blowing agent, and, if desired, 
  d) conventional additives in effective amounts.
Patent AT-E134055-T1 (AT)
Inventor: EHMER CHRISTIAN
IPC: G06F1/00
Filed: 1991-07-31
Granted: 1996-02-15
Abstract: The keyboard input unit consists essentially of a conductor matrix, a keyboard with input keys for coupling mutually crossing conductors, and a control and evaluation circuit (P). In order to prevent spying on an operated key, in the original state, each conductor (A-H) is connected to an ideal source. A conductor interrogation takes place, for example, by connecting a conductor (A-H) to a load-dependent source. If this conductor (A-H) does not assume the value of the load-dependent source, then this conductor (A-H) is coupled at a crossing point (1-28) to another conductor (A-H) through a pressed key. Externally, the original state is simulated. Pressed and released keys are simulated in a similar manner. <IMAGE>
Patent AT-E113021-T1 (AT)
Inventor: MERTENS ARMIN
IPC: B60S9/02
Filed: 1991-11-07
Granted: 1994-11-15
Abstract: Fig. 1 shows a system frame 16 as can be erected on the body frame of a truck. The system frame 16, not described in detail, has at its ends telescopic boxes 3 in which telescopic supports 1, 2 are arranged in a longitudinally displaceable manner. Firmly attached to the ends of the telescopic supports 1, 2 are jacks 17 which can be lowered onto the ground when the telescopic supports are extended so that the military units fastened to the system supports, such as rocket launchers or signal devices, can also project far out to the side without putting the stability of the truck at risk. 
<IMAGE>
Patent AT-E119049-T1 (AT)
Inventor: HOLLANDS KEITH G M
IPC: A61M25/02
Filed: 1991-04-22
Granted: 1995-03-15
Abstract: None of the catheter retainers presently commercially available are entirely satisfactory. Surgeons therefore still quite frequently stitch a catheter to the skin of the wearer. This is frequently done when it is desired to drain a wound and yet hold the wound largely closed. This procedure of course involves a risk of infection and may be painful for the patient. Prior art catheter retainers are unsatisfactory for a number of reasons. Firstly the retainer may be size dependent. In other words, for catheters of different diameter, a different catheter retainer device may be required. Another disadvantage is that known catheter retainers are often hard and rigid, and therefore uncomfortable to wear. Wearing them may promote lesions or maceration of the skin and so give rise to problems other than that for which the patient is in hospital. Another disadvantage of known catheter retainers is that they are hard to clean. Also, when used with catheters which are of a silicone rubber, a material commonly used for catheters, the catheter tubes are hard to lock in position relative to the retainer because of the slipperyness of the tube. As a result, patients can inadvertently pull catheters out. Yet another disadvantage of known catheter retainers is that the clamping pressure which most of them need to apply tends to collapse the catheter or the drainage tube. In consequence, the efficency of drainage is adversely affected. The invented catheter retainer has a pad (10) of medical grade adhesive capable of attachment to the body of a person who has to use a catheter (C1,C2). The pad (10) carries a member (40) to which is secured a cotton or synthetic fibre thread, or a thread of like material. In use the thread is wound around the catheter (C1,C2) and fastened off by being attached to the member (40). The member (40) is preferably slotted (46) for this purpose. <IMAGE>
Patent AT-E162797-T1 (AT)
Inventor: CLAUSSNER ANDRE
IPC: A61K31/56
Filed: 1991-08-09
Granted: 1998-02-15
Abstract: The invention relates to the compounds: <IMAGE>  either n = 1, K = oxygen, R17 = hydroxyl, <IMAGE> R'17 = hydrogen, ethynyl, RA = methyl, RA' = isopropyl, butyl, heptafluorobutyl, X = methylene, phenylene or phenyloxy, Y = -(CH2)7; -(CH2)8-; -(CH2)5-C IDENTICAL C-; -(CH2)q-O-CH2-, q = 5 to 7, and -(CH2)5-S-CH2-, or n = 1 or 2, K = oxygen or sulphur, R17 and R'17 = ketone or R17 = hydroxyl or acyloxy and R'17 = hydrogen, alkyl, alkenyl, alkynyl, X = methylene, arylene, CH2-O, arylenoxy or arylenethio, Y = a bond or aliphatic chain optionally interrupted by arylene, oxygen or sulphur, optionally oxidised, and optionally ending with arylene, Z = bond and if Y and Z = bond, X  NOTEQUAL  CH2 or CH2-O, RA or RA' = hydrogen, alkyl, heterocycle (5 or 6 members) optionally substituted with RA or RA'  NOTEQUAL hydrogen, - or n = 2, or K = sulphur, or X = arylenethio, or RA and RA' = heterocycle substituted by aryl or aralkyl, their preparation, their application as medicinal products and pharmaceutical compositions containing them.
Patent AT-E106668-T1 (AT)
Inventor: WALTER ULRICH
IPC: A21D8/04
Filed: 1990-12-15
Granted: 1994-06-15
Abstract: Cereal flour products are mixed with water and a pitching substance containing microorganisms to form a leaven starter. During the subsequent maturation, the leaven starter undergoes a fermentation process in which, after a lag phase, it passes into an exponential growth phase. To obtain an improved leaven product, a buffering or basic substance is added during the exponential growth phase in order to increase the concentration of revitalizable microorganisms. Measures (cooling or drying) are adopted during the exponential growth phase of the microorganisms with a view to making the product storable.
Patent AT-E103837-T1 (AT)
Inventor: TER MEULEN BEREND PHILIPPUS
IPC: B01D63/04
Filed: 1991-01-03
Granted: 1994-04-15
Abstract: PCT No. PCT/NL91/00001 Sec. 371 Date Jun. 25, 1992 Sec. 102(e) Date Jun. 25, 1992 PCT Filed Jan. 3, 1991 PCT Pub. No. WO91/09668 PCT Pub. Date Jul. 11, 1991.The device is made up of modules comprising a number of hollow membrane fibres or tubes which fibres or tubes are intended for being flowed through by one of the medium flows, while the other medium flows at the outside of said fibres or tubes whose ends project in a sealed manner through module parts lying opposite each other and forming part of chambers having an aperture for feeding or discharging of medium, the feed apertures and discharge apertures of adjacent modules being in register and connected to each other in a liquid-tight manner, the chambers form part of a point-symmetrical frame with a square, polygonal or circular shape and the longitudinal directions of the fibres or tubes of adjacent modules are substantially perpendicular to each other and the feed aperture and discharge aperture of each module have diametrically or diagonally opposite positions. The device can be assembled such that modules thereof are linked together located after one another or next to each other.
Patent AT-E125153-T1 (AT)
Inventor: STEELE GERALD
IPC: A61K9/72
Filed: 1991-01-30
Granted: 1995-08-15
Abstract: Pressurized aerosol composition comprising a liquefied hydrofluorocarbon propellant of formula CxHyFz where x is an integer from 1 to 3, y+z=2x+2, and y and z are both at least 1; from 0.01 to 15% w/w of a particulate medicament dispersed in the liquefied hydrofluorocarbon propellant; and from 0.01 to 10% w/w of a fluorinated surfactant which is soluble in the liquefied hydrofluorocarbon propellant. The pressurized aerosol composition comprises no solvent, other than the liquefied hydrofluorocarbon propellant.
Patent AT-E141178-T1 (AT)
Inventor: WHITE MICHAEL
IPC: B01D29/03
Filed: 1991-02-07
Granted: 1996-08-15
Abstract: The present invention relates to a refractory filter comprising a plurality of filter elements formed from a refractory material having openings therein, said elements being arranged so that openings in one element are substantially staggered with the openings in another element, whereby the fluid path through the elements is tortuous characterised in that (i) the openings in each element are elongate, and (ii) the elements are arranged so that the openings in at least one element are offset with respect to the openings in another element.
Patent AT-E175125-T1 (AT)
Inventor: WIELAND DONALD M
IPC: A61K49/04
Filed: 1991-05-10
Granted: 1999-01-15
Abstract: Radioiodinated benzovesamicol analogs which selectively localize in presynaptic cholinergic neurons of the general formula:  <IMAGE> where X is selected from the group consisting of H, OH, NH2, NHCO-3-[I]-Ph, and a radioactive isotope of iodine, and Y is selected from the group of H and a radioactive isotope of iodine, Y being H is X contains iodine. Illustrative examples include: (+/-)-trans-2-hydroxy-5-iodo-3-(4-phenylpiperidino)tetralin; (+/-)-trans-3-hydroxy-5-iodo-2-(4-phenylpiperidino)tetralin; (+/-)-trans-5-amino-2-hydroxy-8-iodo-3-(4-phenylpiperidino)tetralin; and (+/-)-trans-2-hydroxy-5-(3-iodobenzamido)-3-(4-phenylpiperidino)tetralin. The novel radioiodinated benzovesamicol analogs may be used as radiopharmaceuticals to visualize cholinergic neurons with conventional imaging devices which are typically found in most nuclear medicine or radiology clinics.
Patent AT-E180298-T1 (AT)
Inventor: HAUG ANDREAS
IPC: E03C1/06
Filed: 1992-03-13
Granted: 1999-06-15
Abstract: A showerholder for holding a shower attachment on a wall-slidebar contains a guide element which is displaceably guided on the outside of the wall-slidebar and the length of which is at least twice as much as the diameter of the wall-slidebar. Fixed to the guide element with the aid of at least one strut is a holding device for the shower attachment, which is at a distance from the wall-slidebar which is at least as great as the length of the guide element.
Patent AT-E152252-T1 (AT)
Inventor: JONES J PHILLIP
IPC: G02F1/1333
Filed: 1992-01-21
Granted: 1997-05-15
Abstract: A display having (a) a first electrode; (b) a second electrode; (c) a display medium positioned between the first and second electrodes, which display medium is switchable between a first state in which incident light is at least one of scattered and absorbed and a second state in which the amount of such scattering and/or absorption is reduced; and (d) scattering centers disposed in front of the second electrode for scattering incident light with a scattering half angle of between about 2 and about 40 degrees when the display medium is in its second state, while permitting at least 10% of the incident light to be transmitted.
Patent AT-E139318-T1 (AT)
Inventor: HEDE HANS
IPC: F16L59/04
Filed: 1992-04-29
Granted: 1996-06-15
Abstract: The present invention relates to a method for isolating a spirally wound pipe of a thermoplastic hole profile. The invention is characterized in that through each of the mainly radially directed side walls (2) of a hole profile (1) in the pipe at least one axially directed hole (3, 3a) is made so that a row of holes (3, 3a) located in line with each other is formed through the entire pipe, while the pipe is in a horizontal position and a row of holes (3a) is located uppermost in the pipe, a foaming lancet (4) is introduced into said or another row of holes (3, 3a) through the pipe, a foaming insulating mass (5) is dosed by turns into each segment of the spirally wound pipe after the lancet (4) is stepwise drawn back out of the holes (3, 3a), after which all boring holes (3) on the end surface of the pipe are plugged up, when the foaming is completed.
Patent AT-E220403-T1 (AT)
Inventor: MARUYAMA AKIRA
IPC: A61K31/435
Filed: 1993-03-10
Granted: 2002-07-15
Abstract: The thieno[3.2-b]pyridine derivative of formula (I) of the present invention promotes the gastric emptying in male ddy mice and the gastric contraction in dogs sutured with a strain-gauge transducer. It is believed that the derivative has the action to enhance gastric motor action and gastric emptying. Therefore, the compound of the present invention is effective for the prevention and therapeutical treatment of the symptoms caused by gastric hypanakinesis, such as heartburn, abdominal distension feeling, anorexia, unpleasant feeling on upper abdomen, abdominalgia, nausea, vomiting, etc. caused by the underlying diseases such as acute and chronic gastritis, stomach and duodenum ulcer, gastroneurosis, gastroptosis, etc. The present invention also encompasses a pharmaceutical composition containing as the effective ingredient the compound of the present invention, and a method for producing the same. <CHEM> o
Patent AT-E153505-T1 (AT)
Inventor: BRAGAGLIA GIORGIO
IPC: A24B7/12
Filed: 1993-07-19
Granted: 1997-06-15
Abstract: 1. The cutter comprises:  a support structure (A) in which a shaft (1) is rotatable. At least one blade-holder carriage (5) can rotate with the shaft (1) and carries at least one cutting blade (4) which can cut through and penetrate a block of tobacco (B). The carriage (5) can perform a translatory movement relative to the shaft (1) along a line parallel to the axis of the shaft. A drive device (10 to 16) comprising a plurality of rotary pinions brings about the translatory movement of the carriage (5) and of the associated blade (4) in synchronism with the rotation of the shaft (1) during the cutting of the block of tobacco (B). <IMAGE>